Immune checkpoint inhibitor–associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?-Reference-Cited by-同舟云学术

Immune checkpoint inhibitor–associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Published:2017-12 Issue: Volume:87 Page:205-208
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Strik Herwig^ORCID,Keber Ursula,Hammoud Wasim Alhaj,Riera-Knorrenschild Jorge,Carl Barbara,Dodel Richard,Pagenstecher Axel,Neubauer Andreas

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference12 articles.

1. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial;Westin;Lancet Oncol,2014

2. FDA approval summary: nivolumab for the treatment of metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy;Kazandjian;Oncologist,2016

3. Antagonists of PD-1 and PD-L1 in cancer treatment;Lipson;Semin Oncol,2015

4. Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities;Villadolid;Transl Lung Cancer Res,2015

5. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma;Liao;Neuro Oncol,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-related immune-mediated myelopathies;Frontiers in Neurology;2022-09-29

2. ICI: Immunvermittelte Nebenwirkungen;hautnah dermatologie;2022-09

3. Neurologische Komplikationen unter Immuncheckpointinhibition;Uro-News;2022-06

4. Immune Checkpoint Inhibitors and Neurotoxicity;Current Neuropharmacology;2021-08-11

5. Encephalitis Induced by Immune Checkpoint Inhibitors;JAMA Neurology;2021-07-01